Physical functional status and factors contributing to disability in Japanese chronic dialysis patients

Nephrology

Volumn 4, Issue 3, 1998, Pages 195-203

  Okada, Tomonari ^a   Nakao, Toshiyuki ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic dialysis; Diabetes mellitus; Disability; Functional status; Karnofsky Performance Scale

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DAILY LIFE ACTIVITY; DIABETES MELLITUS; FEMALE; FUNCTIONAL ASSESSMENT; HEMODIALYSIS; HUMAN; JAPAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; OSTEOARTHROPATHY; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; UREA NITROGEN BLOOD LEVEL; VISUAL IMPAIRMENT; WEIGHT GAIN;

EID: 0031928227     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.1998.d01-27.x     Document Type: Article

References (22)

1. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM. (ed.) Evaluation of Chemotherapeutic Agents. New York, Columbia University Press, 1949; 191-205.
2. Gutman RA, Stead WW, Robinson RR. Physical activity and employment status of patients on maintenance hemodialysis patients. N. Engl. J. Med. 1981; 304: 309-13.
3. Evans WE, Mannien DL, Garrison LP et al. The quality of life of patients with end-stage renal disease. N. Engl. J. Med. 1985; 313: 553-9.
4. Carlson DM, Johnson WJ, Kjellstrand CM. Functional status of patients with end-stage renal disease. Mayo Clin. Proc. 1987; 62: 338-44.
5. Lowder GM, Perri NA, Friedman EA. Demographics, diabetes type, and degree of rehabilitation in diabetic patients on maintenance hemodialysis in Brooklyn. J. Dia. Complications 1988; 1: 218-26.
6. Ifudu O, Mayers JD, Matthew J, Tan CC, Cambridge A, Friedman EA. Dismal rehabilitation in geriatric inner-city hemodialysis patients. JAMA 1994; 271: 29-33.
7. Ifudu O, Paul H, Mayers JD et al. Pervasive failed rehabilitation in case-based maintenance hemodialysis patients. Am. J. Kidney Dis. 1994; 23: 394-400.
8. Ifudu O, Brezsnyak WF, Reydel C et al. Pathobiology and functional status of long-term hemodialysis patients. Am. J. Nephrol. 1995; 15: 379-85.
9. Registration committee of the Japanese Soceity for Dialysis Therapy. An overview of regular dialysis treatment in Japan (as of December 31, 1995). Nippon Touseki Igakukai Zasshi. J. Jpn. Soc. Dial. Ther. 1997; 30: 1-25. (In Japanese, with English abstract)
10. D'Amico G. Comparability of the different registries on renal replacement therapy. Am. J. Kidney Dis. 1995; 25: 113-8.
11. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J. Am. Soc. Nephrol. 1993; 4: 1205-13.
12. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N. Engl. J. Med. 1993; 329: 1001-6.
13. Collins AJ, Ma JZ, Umen A. Urea index (Kt/V) and other predictors of hemodialysis patient survival. Am. J. Kidney Dis. 1994; 23: 272-82.
14. Hakim RM, Breyer J, Ismail N, Schlman G. Effects of dose of dialysis on morbidity and mortality. Am. J. Kidney Dis. 1994; 23: 661-9.
15. Holley J, Nespor S. An analysis of factors affecting employment of chronic dialysis patients. Am. J. Kidney Dis. 1994; 23: 681-5.
16. Kutner N, Brogan D, Fielding B. Employment status and ability to work among working-age chronic dialysis patients. Am. J. Nephrol. 1991; 11: 334-40.
17. Curtin RB, Oberley ET, Sacksteder P, Friedman A. Differences between employed and non-employed dialysis patients. Am. J. Kidney Dis. 1996; 21: 533-40.
18. Painter P. The importance of exercise training in rehabilitation on patients with end-stage renal disease. Am. J. Kidney Dis. 1994; 24(Suppl. 1): S2-9.
19. Robertson HT, Haley NR, Guthrie M. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients. Am. J. Kidney Dis. 1990; 15: 325-32.
20. Strihou CY. β2 microglobulin amyloidosis: Effects of ESRF treatment modality and dialysis membrane type. Nephrol. Dial. Transplant 1996; 11(Suppl. 2): 147-9.
21. Hutchinson TA, Boyd NF, Feinstein AR, Gonda A, Hollomby D, Rowat B. Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J. Chron. Dis. 1979; 32: 661-6.
22. Grieco A, Long CJ. Investigation of the Karnofsky performance status as a measure of quality of life. Health Psychology 1984; 3: 129-42.